Literature DB >> 23249840

Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma.

Ngozi E Dufty, Gerry Gilleran, Daniel Hawkins, Laura J Else, Stephen Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23249840     DOI： 10.1093/jac/dks486

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

Review 1.  Chemokine receptor CCR5 antagonist maraviroc: medicinal chemistry and clinical applications.

Authors:  Guoyan G Xu; Jia Guo; Yuntao Wu
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

2.  Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.

Authors:  Alex Ganetsky; Todd A Miano; Mitchell E Hughes; Robert H Vonderheide; David L Porter; Ran Reshef
Journal:  J Antimicrob Chemother       Date:  2015-04-16       Impact factor: 5.790

3.  HIV and Stem Cell Transplantation.

Authors:  Ignacio A Echenique; George E Nelson; Valentina Stosor; Christine M Durand
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.